These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 39017721)
1. Paediatric Uveitis - the uniqueness in clinical presentation and the efficacy of biologics treatment. Yiu MK; Ho M; Ho ACH; Chan WKY; Yung W; Yip WWK; Young AL J Ophthalmic Inflamm Infect; 2024 Jul; 14(1):34. PubMed ID: 39017721 [TBL] [Abstract][Full Text] [Related]
2. Clinical profile and management with immunosuppressants and biologics in Behcet's uveitis: A cohort of 25 patients from a tertiary eye care center in South India. Ramdoss J; Singh P; Ahmed AS; Biswas J Indian J Ophthalmol; 2023 May; 71(5):1972-1976. PubMed ID: 37203067 [TBL] [Abstract][Full Text] [Related]
3. Chronic and recurrent non-infectious paediatric-onset uveitis: a French cohort. Morelle G; Gueudry J; Uettwiller F; Wouters C; Bader-Meunier B; Robert MP; Monnet D; Bodaghi B; Grall-Lerosey M; Quartier P RMD Open; 2019; 5(2):e000933. PubMed ID: 31452929 [TBL] [Abstract][Full Text] [Related]
4. Long Term Experience in Patients With JIA-Associated Uveitis in a Large Referral Center. Marelli L; Romano M; Pontikaki I; Gattinara MV; Nucci P; Cimaz R; Miserocchi E Front Pediatr; 2021; 9():682327. PubMed ID: 34262889 [No Abstract] [Full Text] [Related]
5. Update on the use of systemic biologic agents in the treatment of noninfectious uveitis. Pasadhika S; Rosenbaum JT Biologics; 2014; 8():67-81. PubMed ID: 24600203 [TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes in paediatric tubulointerstitial nephritis and uveitis syndrome (TINU). Mandel M; Elhusseiny AM; Davidson SL; Rockter A; Levin AV; Huang LC; Cheung CSY; Stahl ED; Cooper AM; Jin J; Inger HE; Jordan CO; Jung JL; Utz VM; Angeles-Han ST; Oke I; Nihalani BR Eye (Lond); 2024 Dec; 38(17):3318-3324. PubMed ID: 39085599 [TBL] [Abstract][Full Text] [Related]
7. Rise of biologics in noninfectious uveitis: a retrospective cohort study from Nepal. Sharma S; Kharel R; Parajuli S; Jha S Ann Med Surg (Lond); 2023 May; 85(5):1486-1489. PubMed ID: 37229040 [TBL] [Abstract][Full Text] [Related]
8. The effect of anti-tumor necrosis factor alpha agents on the outcome in pediatric uveitis of diverse etiologies. Deitch I; Amer R; Tomkins-Netzer O; Habot-Wilner Z; Friling R; Neumann R; Kramer M Graefes Arch Clin Exp Ophthalmol; 2018 Apr; 256(4):801-808. PubMed ID: 29455252 [TBL] [Abstract][Full Text] [Related]
9. [Immunosuppressive therapy in severe or chronic pediatric uveitis: Review of the literature]. Stolowy N; Zanin E; Comet A; Jurquet AL; Benso C; Matonti F; Retornaz K; Kaplanski G; Denis D J Fr Ophtalmol; 2021 Feb; 44(2):252-258. PubMed ID: 33423814 [TBL] [Abstract][Full Text] [Related]
10. Anterior and posterior uveitis associated with juvenile idiopathic arthritis -case report. Petrescu L; Crișan M; Lazăr C; Stan C Rom J Ophthalmol; 2022; 66(2):185-190. PubMed ID: 35935079 [TBL] [Abstract][Full Text] [Related]
11. Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis. Woreta F; Thorne JE; Jabs DA; Kedhar SR; Dunn JP Am J Ophthalmol; 2007 Apr; 143(4):647-55. PubMed ID: 17224116 [TBL] [Abstract][Full Text] [Related]
12. Outcomes of early and late immunomodulatory treatment in patients with HLA-B27-associated chronic uveitis. Androudi S; Brazitikos P; Iaccheri B; Fiore T; Christen W; Meniconi M; Foster CS Graefes Arch Clin Exp Ophthalmol; 2003 Dec; 241(12):1000-5. PubMed ID: 14605907 [TBL] [Abstract][Full Text] [Related]
13. Hypopyon in patients with uveitis. Zaidi AA; Ying GS; Daniel E; Gangaputra S; Rosenbaum JT; Suhler EB; Thorne JE; Foster CS; Jabs DA; Levy-Clarke GA; Nussenblatt RB; Kempen JH; Ophthalmology; 2010 Feb; 117(2):366-72. PubMed ID: 20006905 [TBL] [Abstract][Full Text] [Related]
14. Retrospective Study Evaluating Treatment Decisions and Outcomes of Childhood Uveitis Not Associated with Juvenile Idiopathic Arthritis. Sardar E; Dusser P; Rousseau A; Bodaghi B; Labetoulle M; Koné-Paut I J Pediatr; 2017 Jul; 186():131-137.e1. PubMed ID: 28457525 [TBL] [Abstract][Full Text] [Related]
16. Outcomes of non-infectious Paediatric uveitis in the era of biologic therapy. Cann M; Ramanan AV; Crawford A; Dick AD; Clarke SLN; Rashed F; Guly CM Pediatr Rheumatol Online J; 2018 Aug; 16(1):51. PubMed ID: 30081917 [TBL] [Abstract][Full Text] [Related]
17. Incidence rates and risk factors for ocular complications and vision loss in HLA-B27-associated uveitis. Loh AR; Acharya NR Am J Ophthalmol; 2010 Oct; 150(4):534-542.e2. PubMed ID: 20643395 [TBL] [Abstract][Full Text] [Related]
19. Early administration of adalimumab for paediatric uveitis due to Behçet's disease. Hiyama T; Harada Y; Doi T; Kiuchi Y Pediatr Rheumatol Online J; 2019 Jun; 17(1):29. PubMed ID: 31182107 [TBL] [Abstract][Full Text] [Related]
20. Changing biological disease modifying treatment for paediatric uveitis in the real world. Oh LJ; Nguyen CL; Phan K; Wong E; Zagora S; Singh-Grewal D; Chaitow J; Grigg JR; McCluskey P Clin Exp Ophthalmol; 2019 Aug; 47(6):741-748. PubMed ID: 30834650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]